SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-16-002441
Filing Date
2016-03-18
Accepted
2016-03-18 17:08:51
Documents
7
Period of Report
2016-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT f8k031816_8k.htm 8-K 20979
2 EXHIBIT 1.1 UNDERWRITING AGREEMENT f8k031816_ex1z1.htm EX-1.1 147782
3 EXHIBIT 5.1 LEGAL OPINION f8k031816_ex5z1.htm EX-5.1 8975
4 EXHIBIT 99.1 PRESS RELEASE f8k031816_ex99z1.htm EX-99.1 11668
5 EXHIBIT 99.2 PRESS RELEASE f8k031816_ex99z2.htm EX-99.2 10393
6 IMAGE f8k031816_ex5z1001.jpg GRAPHIC 44928
7 IMAGE f8k031816_ex99z2001.jpg GRAPHIC 39867
  Complete submission text file 0001078782-16-002441.txt   316972
Mailing Address 1 SCOTTS RD #24-05 SHAW CENTRE SINGAPORE U0 228208
Business Address 1 SCOTTS RD #24-05 SHAW CENTRE SINGAPORE U0 228208 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36833 | Film No.: 161516833
SIC: 2835 In Vitro & In Vivo Diagnostic Substances